Prevalence of HIV drug resistance before and 1 year after treatment initiation in 4 sites in the Malawi antiretroviral treatment program.
Wadonda-Kabondo N, Bennett D, van Oosterhout JJ, Moyo K, Hosseinipour M, Devos J, Zhou Z, Aberle-Grasse J, Warne TR, Mtika C, Chilima B, Banda R, Pasulani O, Porter C, Phiri S, Jahn A, Kamwendo D, Jordan MR, Kabuluzi S, Chimbwandira F, Kagoli M, Matatiyo B, Demby A, Yang C.
Wadonda-Kabondo N, et al. Among authors: phiri s.
Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S362-8. doi: 10.1093/cid/cir987.
Clin Infect Dis. 2012.
PMID: 22544204
Free PMC article.